Finding the right microbial balance in the gut may be the way of the future for treatment of conditions like obesity and diabetes. That’s where some notable medical futurists are looking and where some early commercial clinical trials are underway. In addition to all the usual uncertainties about new ideas in therapeutics, this idea has an extra question mark: what will the regulatory model be?

Dovetail's goal is to find a non-toxic, small, stable molecule against cancer, starting with myeloma.